Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-12-036953
Filing Date
2012-05-14
Accepted
2012-05-14 16:40:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NOT AUTOMATICALLY EFFECTIVE UPON FILING a12-12020_1posam.htm POS AM 96765
2 EX-5.1 a12-12020_1ex5d1.htm EX-5.1 10687
3 EX-23.2 a12-12020_1ex23d2.htm EX-23.2 3128
  Complete submission text file 0001104659-12-036953.txt   111776
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-177730 | Film No.: 12839260
SIC: 2834 Pharmaceutical Preparations